Skip to main content
Log in

Selective inhibition of leukotriene B4 formation by Ebselen: A novel approach to antiinflammatory therapy

  • New Anti-inflammatory Agents
  • Published:
Agents and Actions Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. M.J. Parnham, S. Leyck, N. Dereu, J. Winkelmann andE. Graf,Ebselen (PZ 51): A GSH-Peroxidase-like Organoselenium Compound with Anti-inflammatory Activity, E. Adv. Inflam. Res., in press.

  2. A. Müller, E. Cadenas, P. Graf andH. Sies,A Novel Biologically Active Seleno-organic Compound-I: Glutathione Peroxidase-like Activity In Vitroand Antioxidant Capacity of PZ 51 (Ebselen), Biochem. Pharmac.33, 3235–3239 (1984).

    Article  Google Scholar 

  3. A. Wendel, M. Fausel, H. Safayhi, G. Tiegs andR. Otter,A Novel Biologically Active Seleno-organic Compound-II: Activity of PZ 51 in Relation to Glutathione Peroxidase, Biochem. Pharmac.33, 3241–3245 (1984).

    Article  Google Scholar 

  4. M.J. Parnham andS. Kindt,A Novel Biologically Active Seleno-organic Compound-III: Effects of PZ 51 (Ebselen) on Glutathione Peroxidase and Secretory Activities of Mouse Macrophages, Biochem. Pharmac.33, 3247–3250 (1984).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kuhl, P., Borbe, H.O., Römer, A. et al. Selective inhibition of leukotriene B4 formation by Ebselen: A novel approach to antiinflammatory therapy. Agents and Actions 17, 366–367 (1986). https://doi.org/10.1007/BF01982648

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01982648

Keywords

Navigation